VYGR Voyager Therapeutics, Inc. Stock Quote

VYGR [NASD]

Index	-	P/E	-	EPS (ttm)	-2.47	Insider Own	0.70%	Shs Outstand	37.78M	Perf Week	-3.79%
Market Cap	108.53M	Forward P/E	-	EPS next Y	-2.16	Insider Trans	-1.21%	Shs Float	32.59M	Perf Month	0.36%
Income	-92.80M	PEG	-	EPS next Q	-0.32	Inst Own	65.10%	Short Float	3.46%	Perf Quarter	-25.40%
Sales	15.90M	P/S	6.83	EPS this Y	181.00%	Inst Trans	13.76%	Short Ratio	2.08	Perf Half Y	-12.54%
Book/sh	2.31	P/B	1.21	EPS next Y	1.30%	ROA	-41.60%	Target Price	6.00	Perf Year	-63.72%
Cash/sh	3.12	P/C	0.89	EPS next 5Y	-	ROE	-76.00%	52W Range	2.46 - 8.03	Perf YTD	2.95%
Dividend	-	P/FCF	-	EPS past 5Y	21.60%	ROI	17.70%	52W High	-64.38%	Beta	1.10
Dividend %	-	Quick Ratio	4.70	Sales past 5Y	58.10%	Gross Margin	-	52W Low	16.26%	ATR	0.17
Employees	177	Current Ratio	4.70	Sales Q/Q	-98.70%	Oper. Margin	-	RSI (14)	48.64	Volatility	6.63% 6.40%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-129.30%	Profit Margin	-	Rel Volume	0.51	Prev Close	2.79
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 02 BMO	Payout	-	Avg Volume	541.11K	Price	2.86
Recom	2.50	SMA20	0.30%	SMA50	-2.40%	SMA200	-20.56%	Volume	86,233	Change	2.51%

Oct-07-21

Upgrade

Robert W. Baird

Neutral → Outperform

$6 → $9

Feb-26-21

Downgrade

Robert W. Baird

Outperform → Neutral

$18 → $6

Feb-03-21

Downgrade

Wedbush

Outperform → Neutral

Feb-03-21

Downgrade

BTIG Research

Buy → Neutral

Dec-24-20

Downgrade

Cantor Fitzgerald

Overweight → Neutral

$15 → $10

Dec-23-20

Downgrade

Raymond James

Outperform → Mkt Perform

Nov-11-20

Downgrade

Oppenheimer

Outperform → Perform

Nov-10-20

Downgrade

Wells Fargo

Overweight → Equal Weight

$10

Nov-10-20

Downgrade

Raymond James

Strong Buy → Outperform

$28 → $17

Mar-19-20

Initiated

The Benchmark Company

Buy

$18

Feb-06-20

Initiated

Oppenheimer

Outperform

Nov-15-18

Upgrade

Raymond James

Outperform → Strong Buy

Sep-10-18

Resumed

BTIG Research

Buy

$32

Sep-10-18

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Jun-04-18

Initiated

H.C. Wainwright

Buy

$30

Mar-12-18

Downgrade

Wedbush

Outperform → Neutral

$29

Mar-12-18

Downgrade

Evercore ISI

Outperform → In-line

Feb-02-18

Initiated

Morgan Stanley

Overweight

Nov-28-17

Resumed

Piper Jaffray

Overweight

$28

Oct-31-17

Initiated

Robert W. Baird

Outperform

$31

Jan-26-22 05:15PM	Vertex Pharmaceuticals (VRTX) Surpasses Q4 Earnings and Revenue Estimates Zacks
Dec-14-21 01:25PM	Shareholders in Voyager Therapeutics (NASDAQ:VYGR) are in the red if they invested five years ago Simply Wall St. -6.42%
Nov-19-21 07:30AM	Voyager Therapeutics Announces Positive Preclinical Data from New Vectorized anti-HER2 Antibody Program at the 26th Society for Neuro-Oncology Annual Meeting GlobeNewswire
Nov-17-21 03:01AM	These 40 Mass. companies made the new Deloitte Fast 500 list American City Business Journals
Nov-16-21 07:00AM	Voyager Therapeutics to Present Preclinical Data from Vectorized Antibody Program at the 26th Society for Neuro-Oncology Annual Meeting GlobeNewswire
Nov-02-21 08:25AM	Voyager Therapeutics (VYGR) Reports Q3 Loss, Lags Revenue Estimates Zacks
07:00AM	Voyager Therapeutics Reports Third Quarter 2021 Financial and Operating Results GlobeNewswire
Nov-01-21 03:02PM	Earnings Preview: Voyager Therapeutics (VYGR) Q3 Earnings Expected to Decline Zacks
Oct-20-21 08:54AM	Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy at Virtual Congress of the European Society of Gene and Cell Therapy GlobeNewswire -7.19%
Oct-14-21 11:30AM	Is Voyager Therapeutics, Inc. (NASDAQ:VYGR) Popular Amongst Institutions? Simply Wall St.
Oct-07-21 12:55PM	Is Voyager Stock a Buy Following Pfizer Deal? This Is What You Need to Know TipRanks
10:23AM	Voyager (VYGR) Surges on Gene Therapy Deal With Pfizer Zacks
08:30AM	Implied Volatility Surging for Voyager (VYGR) Stock Options Zacks
Oct-06-21 12:37PM	5 Top Stock Gainers for Wednesday: Marvell, Voyager Therapeutics TheStreet.com +56.68%
12:08PM	Mid-Day Market Update: Dow Tumbles Over 300 Points; Acer Therapeutics Shares Jump Benzinga
10:23AM	Mid-Morning Market Update: Markets Open Lower; Acuity Brands Posts Upbeat Q4 Results Benzinga
10:18AM	Voyager Therapeutics Stock Had Been Beaten Down. Heres Why Its Soaring. Barrons.com
08:01AM	Voyager Therapeutics Stock Soars on Potential $630M Deal With Pfizer TheStreet.com
07:32AM	Voyager Therapeutics stock rockets after license option deal with Pfizer that could be valued at $630 million MarketWatch
07:00AM	Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACER AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs GlobeNewswire
Sep-02-21 05:08PM	Voyager Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-15-21 04:14AM	What You Need To Know About The Voyager Therapeutics, Inc. (NASDAQ:VYGR) Analyst Downgrade Today Simply Wall St.
Aug-10-21 04:20PM	Voyager Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire -11.40%
Aug-09-21 08:25AM	Voyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates Zacks +6.04%
07:00AM	Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER AAV Capsid and Vectorized Antibody Platform Technologies GlobeNewswire
Aug-02-21 03:01PM	Analysts Estimate Voyager Therapeutics (VYGR) to Report a Decline in Earnings: What to Look Out for Zacks +5.40%
Jun-30-21 07:58AM	Is Weakness In Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? Simply Wall St.
May-19-21 04:01PM	Voyager Therapeutics Announces Strategic Shift and Leadership Transitions GlobeNewswire
May-12-21 10:20AM	Voyager Therapeutics' Vectorized Anti-Tau Antibody Shows Encouraging Preclinical Data In CNS Disorders Benzinga
07:30AM	Voyager Therapeutics Presents New Preclinical Data Showing Reduction of Pathological Tau with Vectorized Anti-Tau Antibody GlobeNewswire
May-11-21 07:30AM	Voyager Therapeutics Novel Capsids Demonstrate Robust Delivery Across the Blood Brain Barrier, Widespread CNS Transduction in Non-Human Primates GlobeNewswire +7.06%
May-10-21 08:45AM	Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:30AM	Voyager Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates GlobeNewswire
Apr-29-21 10:50AM	What Kind Of Shareholders Hold The Majority In Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Shares? Simply Wall St.
Apr-28-21 12:33PM	Earnings Preview: Voyager Therapeutics (VYGR) Q1 Earnings Expected to Decline Zacks
08:00AM	Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2021 Annual Meeting GlobeNewswire
Apr-27-21 10:10AM	10 Best Stocks for Beginners with Little Money Insider Monkey -6.07%
08:05AM	Strength Seen in Voyager Therapeutics (VYGR): Can Its 16.5% Jump Turn into More Strength? Zacks
Apr-26-21 09:32AM	Voyager Therapeutics' Stock Jumps As FDA Lifts Clinical Hold For Huntington's Disease Gene Therapy Benzinga +16.49%
08:00AM	Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntingtons Disease GlobeNewswire
Apr-20-21 10:51AM	10 Best Biotech Stocks Under $6 in 2021 Insider Monkey
Mar-24-21 10:08AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile -9.25%
10:00AM	VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 GlobeNewswire
02:10AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR PR Newswire
Mar-23-21 06:45PM	VYGR FINAL DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline in Securities Class Action - VYGR PR Newswire -10.56%
06:05PM	FINAL DEADLINE ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors with Losses over $100K to Secure Counsel Before Important March 24 Deadline in Securities Class Action - VYGR Newsfile
01:00PM	VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: March 24, 2021 ACCESSWIRE
08:30AM	DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Mar-22-21 01:00PM	VYGR Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: March 24, 2021 ACCESSWIRE
08:30AM	WEDNESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Mar-21-21 08:06PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR Newsfile
02:20PM	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline in Securities Class Action VYGR GlobeNewswire
Mar-19-21 10:29AM	WEDNESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile +6.74%
Mar-18-21 06:14PM	ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline in Securities Class Action - VYGR Newsfile
05:25PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR PR Newswire
10:26AM	WEDNESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:00AM	BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm GlobeNewswire
12:50AM	INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Mar-17-21 04:17PM	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline in Securities Class Action VYGR Business Wire
02:20PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:00AM	BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
10:25AM	7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Mar-16-21 08:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline VYGR ACCESSWIRE
11:00AM	BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Shareholders to Contact the Firm ACCESSWIRE
Mar-15-21 12:40PM	INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:00AM	BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
Mar-14-21 10:54PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR Newsfile
Mar-12-21 06:00PM	ROSEN, A TOP RANKED LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors with Large Losses to Secure Counsel Before Important March 24 Deadline VYGR GlobeNewswire
05:45PM	ROSEN, A TOP RANKED LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors with Large Losses to Secure Counsel Before Important March 24 Deadline VYGR GlobeNewswire
02:34PM	INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire
04:05AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR PR Newswire
Mar-11-21 11:45AM	SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Mar-10-21 09:56PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline VYGR ACCESSWIRE
Mar-09-21 04:40PM	Rosen, Global Investor Counsel, Encourages Voyager Therapeutics, Inc. Investors with Large Losses to Secure Counsel Before Important March 24 Deadline - VYGR Newsfile +6.18%
11:00AM	FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:00AM	BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
Mar-08-21 09:15PM	ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors With Large Losses to Secure Counsel Before Important March 24 Deadline - VYGR PR Newswire
12:30PM	SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Mar-07-21 12:44PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR Newsfile
Mar-06-21 11:30AM	EQUITY LOSS ALERT: Rosen, Global Investor Counsel, Encourages Voyager Therapeutics, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline VYGR ACCESSWIRE
Mar-05-21 11:55AM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Mar-03-21 04:12PM	VOYAGER THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Voyager Therapeutics, Inc. GlobeNewswire
03:40PM	VYGR Breaking Notice: Rosen, Top Ranked Investor Counsel, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline - VYGR Newsfile
01:10AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR PR Newswire
Mar-02-21 12:55PM	FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE -5.03%
11:00AM	BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
Mar-01-21 12:20AM	SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE +5.29%
Feb-28-21 02:41AM	Things Look Grim For Voyager Therapeutics, Inc. (NASDAQ:VYGR) After Today's Downgrade Simply Wall St.
Feb-27-21 09:00AM	VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline VYGR GlobeNewswire
Feb-26-21 10:04AM	Benzinga's Top Ratings Upgrades, Downgrades For February 26, 2021 Benzinga -8.99%
Feb-25-21 10:14PM	VYGR BREAKING NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline - VYGR PR Newswire -5.46%
04:01PM	Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates GlobeNewswire
02:30PM	Voyager Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
01:19PM	INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire
Feb-24-21 02:04PM	VYGR Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm Business Wire
11:45AM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Feb-23-21 07:45PM	ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline VYGR GlobeNewswire
11:50AM	INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:20AM	BTBT, VYGR & AZN Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
Feb-22-21 03:16PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR Newsfile

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia. The company has strategic collaboration agreements with the University of Massachusetts; and ClearPoint Neuro, Inc., as well as collaborations with Thermo Fisher Scientific and Fujifilm Diosynth Biotechnologies to support the development of its gene therapy programs. It also has a collaboration and license agreement with Neurocrine Biosciences, Inc. for the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Burek Julie	VP, Finance	Jan 12	Sale	3.06	265	811	46,257	Jan 14 06:14 PM
Burek Julie	VP, Finance	Jan 03	Sale	2.83	3,063	8,668	46,522	Jan 14 06:14 PM
Khwaja Omar	See remarks	May 21	Sale	4.03	3,516	14,169	120,509	May 25 04:31 PM
Turenne Andre	President & CEO	Feb 11	Sale	7.55	7,977	60,226	148,375	Feb 16 04:11 PM
Dorval Allison	Chief Financial Officer	Feb 11	Sale	7.55	3,186	24,054	45,894	Feb 16 04:10 PM
Hesslein Robert W.	Senior VP & General Counsel	Feb 11	Sale	7.55	3,186	24,054	49,348	Feb 16 04:08 PM
Khwaja Omar	See remarks	Feb 11	Sale	7.55	3,475	26,236	53,025	Feb 16 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience